Share this article on:

147 Developing AIDS Associated Cancer Research in Africa

Adebamowo Clement
JAIDS Journal of Acquired Immune Deficiency Syndromes: April 2012
doi: 10.1097/01.qai.0000413767.89060.7f

Given the state of infrastructure and resources in Africa, development of cancer research is going to be a challenge. Carefully developed and systematic research program that takes advantage of existing infrastructure particularly that provided by the unprecedented investment in health care infrastructure, training and logistics that occurred through the PEPFAR program; proactive identification, local and international training and mentoring of local faculty; careful prioritization of research agenda are required for a successful long term research collaborations. Since July 2009, IHV, IHVN and collaborators in Nigeria have engaged in development of AIDS Associated Cancer Research and have laid foundations for future collaboration. 2 cervical cancer screening and treatment programs have provided service for 2002 women in the last 12 months and found 6.8% VIA positivity, 0.2% cervical cancer and 0.2% uncertain lesions prevalence. This nurse provider led program uses off the shelf digital camera to do digital cervicography that is reviewed weekly for QA/QC by gynecologist. VIA+ lesions are treated with cold coagulation and there has been no complication. A case control study of HPV and Cervical Premalignant lesion in HIV+ and HIV− women is scheduled to start shortly taking advantage of this platform. 4 cancer registration and epidemiology trainings have been conducted for 20 cancer registries, 5 of which are now at the level of population based cancer registries providing good quality data. This data will be analyzed and published as first national cancer incidence and survival data from Nigeria. Upon completion of the IHVN data center, an AIDS Cancer Match analysis is scheduled for shortly after.

© 2012 Lippincott Williams & Wilkins, Inc.